LENZ THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
LENZ THERAPEUTICS, INC. (LENZ) reported Earnings Per Share, Basic and Diluted of -$0.48 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- LENZ THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.48.
- LENZ THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.35.
- LENZ THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.28.
- LENZ THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$3.45.
- LENZ THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.45.
- LENZ THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$29.93.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.48 10-Q · filed 2022-05-12 | -$0.83 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.11 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2021-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$2.45 10-K · filed 2022-03-21 |
| 2021-09-30 | -$0.28 10-Q · filed 2021-11-10 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$2.51 10-Q · filed 2021-11-10 | -$7.13 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$3.45 10-Q · filed 2021-08-12 | -$8.45 10-Q · filed 2021-08-12 | -$25.36 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$27.22 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-03-31 | -$5.75 10-Q · filed 2022-05-12 | -$24.36 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$25.44 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$28.04 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2020-12-31 | -$18.63 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$19.70 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$22.44 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$29.93 10-K · filed 2022-03-21 |
| 2020-09-30 | -$1.00 10-Q · filed 2021-11-10 | -$1.64 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.53 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$0.56 10-Q · filed 2021-08-12 | -$1.25 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |